Mesalamine Capsule, Extended Release
Product Images NDC 60687-650

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 3 technical images submitted to the FDA as part of the official labeling for Mesalamine (NDC 60687-650). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by American Health Packaging, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

0.375 G Mesalamine Extended-release Capsule Blister (Blister)

0.375 G Mesalamine Extended-release Capsule Blister (Blister)
This is a description for two lots of Mesalamine Extended-Release Capsules, USP 0.375g produced by American Health Packaging. The expiry dates are not given, as they are marked as xx/xx. The lot numbers are 000000 and 3000000. The has made some errors, producing some gibberish near the end.*
FDA Label Image

0.375 G Mesalamine Extended-release Capsules Carton (Carton)

0.375 G Mesalamine Extended-release Capsules Carton (Carton)
NDC 60687-650-32 is a prescription drug package of 20 extended-release capsules of Mesalamine. Each capsule contains 03759 of Mesalamine. The package is manufactured by American Health Packaging and distributed by Ascend Laboratories, LLC. The usual dosage is mentioned in the package insert for full prescribing information. It should be stored between 207 to 25°C and kept out of reach of children. It is advised not to use the drug if the blister is torn or broken.*
FDA Label Image

Structural Formula (Structure)

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.